- $212.22m
- $314.22m
- $447.61m
- 59
- 50
- 40
- 48
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 419 | 383 | 396 | 430 | 448 |
Cost of Revenue | |||||
Gross Profit | 163 | 150 | 160 | 160 | 154 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 418 | 370 | 384 | 422 | 445 |
Operating Profit | 0.583 | 12.5 | 12.3 | 8.15 | 2.38 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.3 | 5.69 | -4.56 | -2 | -6.79 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.4 | 3.83 | -6.31 | -5.35 | -9.28 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -16.4 | 3.83 | -6.31 | -5.35 | -9.28 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16.4 | 3.83 | -6.31 | -5.35 | -9.28 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.188 | 0.042 | 0.002 | -0.058 | -0.079 |